These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 34685644)
1. The Role of Insulin-like Growth Factor-1 (IGF-1) in the Control of Neuroendocrine Regulation of Growth. Al-Samerria S; Radovick S Cells; 2021 Oct; 10(10):. PubMed ID: 34685644 [TBL] [Abstract][Full Text] [Related]
2. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid. Kamegai J; Unterman TG; Frohman LA; Kineman RD Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507 [TBL] [Abstract][Full Text] [Related]
3. Acetylcholine Modulates the Hormones of the Growth Hormone/Insulinlike Growth Factor-1 Axis During Development in Mice. Lecomte MJ; Bertolus C; Ramanantsoa N; Saurini F; Callebert J; Sénamaud-Beaufort C; Ringot M; Bourgeois T; Matrot B; Collet C; Nardelli J; Mallet J; Vodjdani G; Gallego J; Launay JM; Berrard S Endocrinology; 2018 Apr; 159(4):1844-1859. PubMed ID: 29509880 [TBL] [Abstract][Full Text] [Related]
4. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis. Luque RM; Gahete MD; Valentine RJ; Kineman RD J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921 [TBL] [Abstract][Full Text] [Related]
5. Targeted deletion of somatotroph insulin-like growth factor-I signaling in a cell-specific knockout mouse model. Romero CJ; Ng Y; Luque RM; Kineman RD; Koch L; Bruning JC; Radovick S Mol Endocrinol; 2010 May; 24(5):1077-89. PubMed ID: 20211984 [TBL] [Abstract][Full Text] [Related]
6. Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats. Kappeler L; Zizzari P; Grouselle D; Epelbaum J; Bluet-Pajot MT J Neuroendocrinol; 2004 Dec; 16(12):980-8. PubMed ID: 15667453 [TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Maccario M; Tassone F; Grottoli S; Rossetto R; Gauna C; Ghigo E Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 1):140-4. PubMed ID: 11994678 [TBL] [Abstract][Full Text] [Related]
8. Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment. Kovacs M; Kineman RD; Schally AV; Flerko B; Frohman LA J Neuroendocrinol; 2000 Apr; 12(4):335-41. PubMed ID: 10718930 [TBL] [Abstract][Full Text] [Related]
9. Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus. Szabo M; Butz MR; Banerjee SA; Chikaraishi DM; Frohman LA Endocrinology; 1995 Sep; 136(9):4044-8. PubMed ID: 7649113 [TBL] [Abstract][Full Text] [Related]
11. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Ceda GP; Davis RG; Rosenfeld RG; Hoffman AR Endocrinology; 1987 Apr; 120(4):1658-62. PubMed ID: 3104015 [TBL] [Abstract][Full Text] [Related]
12. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans. Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509 [TBL] [Abstract][Full Text] [Related]
13. The regulation of reproductive neuroendocrine function by insulin and insulin-like growth factor-1 (IGF-1). Wolfe A; Divall S; Wu S Front Neuroendocrinol; 2014 Oct; 35(4):558-72. PubMed ID: 24929098 [TBL] [Abstract][Full Text] [Related]
14. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I. Sjögren K; Jansson JO; Isaksson OG; Ohlsson C Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852 [TBL] [Abstract][Full Text] [Related]
15. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations. Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues. Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte GH-axis hormones in immunity. Weigent DA Cell Immunol; 2013; 285(1-2):118-32. PubMed ID: 24177252 [TBL] [Abstract][Full Text] [Related]